HUL rises on entering into `Health & Wellbeing` category with strategic investments in OZiva, Nutritionalab
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Hindustan Unilever is currently trading at Rs. 2732.00, up by 30.70 points or 1.14% from its previous closing of Rs. 2701.30 on the BSE.
The scrip opened at Rs. 2724.50 and has touched a high and low of Rs. 2741.00 and Rs. 2712.00 respectively. So far 29547 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2,741.00 on 09-Dec-2022 and a 52 week low of Rs. 1901.80 on 08-Mar-2022.
Last one week high and low of the scrip stood at Rs. 2,741.00 and Rs. 2585.00 respectively. The current market cap of the company is Rs. 641203.46 crore.
The promoters holding in the company stood at 61.90%, while Institutions and Non-Institutions held 25.81% and 12.31% respectively.
Hindustan Unilever (HUL) has forayed into the ‘Health & Wellbeing’ category through strategic investments in Zywie Ventures (OZiva) and Nutritionalab (Wellbeing Nutrition). ‘Health & Wellbeing’ is a fast-evolving category in India with a total potential market size of Rs 30,000 crore.
The company will acquire 51% equity stake in Zywie Ventures through a combination of primary infusion and secondary buyouts for a consideration of Rs 264.28 crore. The balance 49% will be acquired at the end of 36 months based on pre-agreed valuation criteria. Besides, the company will also acquire 19.8% equity stake in Nutritionalab through a combination of primary infusion and secondary buyouts for a cash consideration of Rs 70 crore. Both these transactions are expected to be completed in the next 1-3 months, subject to customary closing conditions.
Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments.
